The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs

Basic Research in Cardiology

Volumn 102, Issue 3, 2007, Pages 245-256

  Li, Yue ^a   Li, Wei Min ^a   Gong, Yong Tai ^a   Li, Bao Xin ^a   Liu, Wei ^a   Han, Wei ^a   Dong, Deli ^a   Sheng, Li ^a   Xue, Jing Yi ^a   Zhang, Li ^a   Chu, Shan ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin; Atrial fibrillation; Calpains; Dog; Structural remodelling

Indexed keywords

CALPAIN; CILAZAPRIL; MESSENGER RNA; SILICON; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTRODE; ELECTRON MICROSCOPY; GENE EXPRESSION; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE CELL; NONHUMAN; PACEMAKER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CALPAIN; CILAZAPRIL; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART ATRIA; MALE; MYOCYTES, CARDIAC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLES; VALINE;

EID: 34147144966     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0641-8     Document Type: Article

References (35)

1. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN (1999) Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 34:1577-1586
2. Ak K, Akgun S, Tecimer T, Isbir CS,Civelek A, Tekeli A, Arsan S, Cobanoglu A (2005) Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg 79:1970-1975
3. Allessie M, Ausma J, Schotten U (2002)Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230-246
4. Ausma J, Van der Velden H, Lenders MH, Duimel H, Borgers M, Allessie MA(2001) Partial recovery from structural atrial remodeling after prolonged atrial fibrillation. Circulation 104 (Suppl II):II/77
5. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M (1997) Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96:3157-3163
6. Brundel BJ, Ausma J, van Gelder IC, Vander Want JJ, van Gilst WH, Crijns HJ, Henning RH (2002) Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 54:315-324
7. Brundel BJ, Kampinga HH, Henning RH (2004) Calpain inhibition prevent spacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res 62:521-528
8. Contard F, Koteliansky V, Marotte F, Dubus I, Rappaport L, Samuel JL (1991)Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab Invest 64:65-75
9. Dai Y, Wang X, Cao L, Wu T (2004) Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci 24:32-36
10. Everett TH 4th, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA, Haines DE (2000) Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 102:1454-1460
11. Fogari R, Mugellini A, Destro M, CorradiL, Zoppi A, Fogari E, Rinaldi A(2006) Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol47:46-50
12. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997)Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180-1184
13. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Reed JC, Fritz H, Fuentes-Prior P, Spiess E, Salvesen GS, Machleidt W (2002) Ionomycin-activated calpa in triggers apoptosis. A probable role forBcl-2 family members. J Biol Chem 227:27217-27226
14. Godtfredsen J (1975) Atrial fibrillation Etiology, Course and Prognosis. A Follow-up Study of 1212 Cases. Copenhagen:UNiversity of Copenhagen
15. Goette A, Arndt M, Rocken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U (2002)Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283:H264-H272
16. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer S (2003)Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: Role of DNA damage. Am J Physiol Heart Circ Physiol 285:H2364-H2372
17. Hirayama Y, Atarashi H, Kobayashi Y, Horie T, Iwasaki Y, Maruyama M, Miyauchi Y, Ohara T, Yashima M, Takano T (2005) Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J 69:671-676
18. Kinebuchi O, Mitamura H, Shiroshita-Takeshita A, Kurita Y, Ieda M, Ohashi N, Fukuda Y, Sato T, Miyoshi S, Hara M, Takatsuki S, Nagumo M, Ogawa S (2004)Oral verapamil attenuates the progressiono f pacing-induced electrical and mechanical remodeling of the atrium.Circ J 68:494-500
19. Kossmehl P, Kurth E, Faramarzi S, Habighorst B, Shakibaei M, Wehland M, Kreutz R, Infanger MJ, Danser AH, Grosse J, Paul M, Grimm D (2006) Mechanisms of apoptosis after ischemia and reperfusion: Role of the renin-angiotensin system. Apoptosis 11:347-358
20. Li Y, Li WM, Xue JY, Han W, Yang SS, Gu HY (2004) An experimental study on the effects of cilazapril on atrial remodeling in atrial fibrillation dogs. Zhonghua Xin Xue Guan Bing] Za Zhi32:1033
21. Lukkarinen HP, Laine J, Aho H, Zagariya A, Vidyasagar D, Kaapa PO(2005) Angiotensin II receptor inhibition prevents pneumocyte apoptosis in surfactant-depleted rat lungs. Pediatr Pulmonol 39:349-358
22. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, Douglas PS (1995) Temporal dependence of the return of atrial mechanical function on the mode of cardio version of atrial fibrillation to sinus rhythm. Am J Cardiol 75:624-626
23. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K (2000)Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101:2612-2617
24. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100:376-380
25. Sandmann S, Yu M, Unger T (2001)Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction - effects of AT(1)and AT(2) receptor antagonists and ACE inhibitor. Br J Pharmacol 132:767-777
26. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA(2001) Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103:691-698
27. Schotten U, de Haan S, Neuberger HR, Eijsbouts S, Blaauw Y, Tieleman R, Allessie M (2004) Loss of atrial contractility is primary cause of atrial dilatation during first days of atrial fibrillation. Am J Physiol Heart Circ Physiol 5:H2324-H2331
28. Sharma AK, Rohrer B (2004) Calcium induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 279:35564-35572
29. Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC (2001) Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52:217-225
30. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M (2000)Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 9:17-28
31. Touyz RM, Sventek P, Lariviere R, Thibault G, Fareh J, Reudelhuber T, Schiffrin EL (1996) Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27:1090-1096
32. Wang KK (2000) Calpain and caspase:cAn you tell the difference? Trends Neurosci 23:20-26
33. Willems R, Sipido KR, Holemans P, Ector H, Van de Werf F, Heidbuchel H(2001) Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation. J Cardiovasc Electrophysiol 12:1387-1392
34. Yue L, Feng J, Gaspo R, Li GR,Wang Z, Nattel S (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81:512-525
35. Yu WC, Lee SH, Tai CT, Tsai CF, Hsieh MH, Chen CC, Ding YA, Chang MS,Chen SA (1999) Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 42:470-476